Literature DB >> 24236680

When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption.

Robert W Dubois1, Michael Lauer, Eleanor Perfetto.   

Abstract

Translation of medical evidence into practice has not kept pace with the growth of medical technology and knowledge. We present three case studies--statins, drug eluting stents and bone marrow transplantation for breast cancer--to propose a framework for describing five factors that may influence the rate of adoption. The factors are: validity, reliability and maturity of the science available before widespread adoption; communication of the science; economic drivers; patients' and physicians' ability to apply published scientific findings to their specific clinical needs; and incorporation into practice guidelines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24236680     DOI: 10.2217/cer.13.39

Source DB:  PubMed          Journal:  J Comp Eff Res        ISSN: 2042-6305            Impact factor:   1.744


  5 in total

1.  Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years.

Authors:  Suzanne C O'Neill; Claudine Isaacs; Calvin Chao; Huei-Ting Tsai; Chunfu Liu; Bola F Ekezue; Nandini Selvam; Larry G Kessler; Marc D Schwartz; Tania Lobo; Arnold L Potosky
Journal:  J Natl Compr Canc Netw       Date:  2015-10       Impact factor: 11.908

2.  Health technology assessment in Switzerland: a descriptive analysis of "Coverage with Evidence Development" decisions from 1996 to 2013.

Authors:  Urs Brügger; Bruno Horisberger; Alexander Ruckstuhl; Rafael Plessow; Klaus Eichler; Alois Gratwohl
Journal:  BMJ Open       Date:  2015-03-27       Impact factor: 2.692

3.  Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative.

Authors:  Katherine Deane; Laure Delbecque; Oleksandr Gorbenko; Anne Marie Hamoir; Anton Hoos; Begonya Nafria; Chi Pakarinen; Ify Sargeant; Dawn P Richards; Soren Eik Skovlund; Nicholas Brooke
Journal:  BMJ Innov       Date:  2019-03-02

4.  Why Not? Persuading Clinicians to Reduce Overuse.

Authors:  Susan C Chimonas; Katherine L Diaz-MacInnis; Allison N Lipitz-Snyderman; Brooke E Barrow; Deborah R Korenstein
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-06-05

5.  Co-creating with patients an impact framework across the medicine's life cycle: a qualitative study exploring patients' experiences of involvement in and perceptions of impact measures.

Authors:  Oleks Gorbenko; Pascale Cavillon; Rachel H Giles; Teodora Kolarova; Muriël Marks; Antonella Cardone; Sandeep Bagga; Claire Nolan
Journal:  Res Involv Engagem       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.